Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug-eluting stent pricing

This article was originally published in The Gray Sheet

Executive Summary

J&J/Cordis's apparent European drug-eluting stent bundling scheme will ultimately impair the firm's ability to compete once competitors launch similar devices in Europe, according to Boston Scientific. "J&J's most recent pricing list, which offers a range of prices down to $1,500, is very explicitly not a geographically-based price list, but a volume-based price list," Boston Scientific Cardiovascular President Paul LaViolette tells investors April 16. "I think the reception in the market place to that pricing scheme is generally negative, so it will be less an issue of us fending off J&J from bundling and more of an issue of the customers battling J&J." Cordis launched the Cypher sirolimus-eluting stent April 12, following CE mark approval. Boston Scientific expects a CE mark for its NIRx in approximately six months...

You may also be interested in...



New EU Approvals

The Pink Sheet’s list of EU centralized approvals of new active substances has been updated with seven new products including Roche's Polivy for treating diffuse large B-cell lymphoma. The list, which contains information dating back to January 2018, includes brand name, generic name, company, therapeutic indication, date of marketing authorization and product type (eg, medicine, vaccine, biologic).

Cosmetics Weekly Trademark Review: 14 January 2020

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.

Cosmetics Weekly Trademark Review: 7 January 2020

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps.
UsernamePublicRestriction

Register

MT016438

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel